Johnson & Johnson (JNJ) Income from Discontinued Operations (2022 - 2023)
Johnson & Johnson's (JNJ) quarterly Income from Discontinued Operations came in at -$83.0 million in Q4 2023, down 128.33% year-over-year from $293.0 million in Q4 2022, and down 100.38% quarter-over-quarter from $21.7 billion in Q4 2023.
Analysis
Johnson & Johnson (JNJ) Income from Discontinued Operations (2022 - 2023) Analysis & Trends
Johnson & Johnson has disclosed Income from Discontinued Operations across 2 years of filings, most recently posting -$83.0 million for Q4 2023.
- In Q4 2023, Income from Discontinued Operations fell 128.33% year-over-year to -$83.0 million; the TTM figure through Sep 2024 stood at -$83.0 million (down 100.37% YoY), while the FY2023 annual figure was $21.8 billion, up 1289.37% from the prior year.
- Income from Discontinued Operations came in at -$83.0 million for Q4 2023 at Johnson & Johnson, down from $21.7 billion in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $21.7 billion in Q4 2023 to a low of -$232.0 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 8.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -83.00 Mn |
| Oct 1, 2023 | 21.72 Bn |
| Jul 2, 2023 | -232.00 Mn |
| Apr 2, 2023 | 423.00 Mn |
| Jan 1, 2023 | 293.00 Mn |
| Oct 2, 2022 | 148.00 Mn |
| Jul 3, 2022 | 552.00 Mn |
| Apr 3, 2022 | 578.00 Mn |